Skip to Content

TherapeuticsMD Inc TXMD

Morningstar Rating
$1.84 +0.03 (1.66%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TXMD is trading at a 487% premium.
Price
$1.82
Fair Value
$6.69
Uncertainty
Extreme
1-Star Price
$87.64
5-Star Price
$9.32
Economic Moat
Lvpy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TXMD is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.81
Day Range
$1.811.88
52-Week Range
$1.434.35
Bid/Ask
$1.65 / $2.00
Market Cap
$21.22 Mil
Volume/Avg
6,836 / 16,427

Key Statistics

Price/Earnings (Normalized)
Price/Sales
16.70
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
1

Valuation

Metric
TXMD
Price/Earnings (Normalized)
Price/Book Value
0.74
Price/Sales
16.70
Price/Cash Flow
Price/Earnings
TXMD

Financial Strength

Metric
TXMD
Quick Ratio
1.17
Current Ratio
1.78
Interest Coverage
Quick Ratio
TXMD

Profitability

Metric
TXMD
Return on Assets (Normalized)
−10.65%
Return on Equity (Normalized)
−17.78%
Return on Invested Capital (Normalized)
−13.95%
Return on Assets
TXMD
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
QkdqtvltfGmbcm$81.5 Bil
Merck KGaA ADR
MKKGY
MbptxbrvpkYhswk$71.1 Bil
Haleon PLC ADR
HLN
YgnrrbthwPpjc$40.4 Bil
Viatris Inc
VTRS
CvdgrvpkpRymmr$14.1 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
QfwcpssrtVgbcm$13.2 Bil
Catalent Inc
CTLT
GnfghhgpHtzbkr$10.5 Bil
Perrigo Co PLC
PRGO
RllsgkbFxkb$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
QdcxxnwdPgzdzb$3.5 Bil
Curaleaf Holdings Inc
CURLF
XgvmdghhjJbh$3.1 Bil
Green Thumb Industries Inc
GTBIF
MdnrwdjqHlqtv$2.7 Bil

Sponsor Center